GPN3
GPN-loop GTPase 3
Also known as: ATPBD1C, GPN3_HUMAN, MGC14560
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UHW5
- Gene
- GPN3
- Ensembl
- ENSG00000111231
- Chromosome
- 12
- Canonical length
- 284 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nuclear speckles,Cytosol
OverviewNCBI Gene
Predicted to enable GTPase activity. Part of protein-containing complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
284 residues, UniProt reviewed canonical sequence.
>Q9UHW5|GPN3
1 MPRYAQLVMG PAGSGKSTYC ATMVQHCEAL NRSVQVVNLD PAAEHFNYSV MADIRELIEV
61 DDVMEDDSLR FGPNGGLVFC MEYFANNFDW LENCLGHVED DYILFDCPGQ IELYTHLPVM
121 KQLVQQLEQW EFRVCGVFLV DSQFMVESFK FISGILAALS AMISLEIPQV NIMTKMDLLS
181 KKAKKEIEKF LDPDMYSLLE DSTSDLRSKK FKKLTKAICG LIDDYSMVRF LPYDQSDEES
241 MNIVLQHIDF AIQYGEDLEF KEPKEREDES SSMFDEYFQE CQDELocalizationUniProt · AlphaFold · HPA
Whether an antibody against GPN3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 48 nTPM
Expression across tissuesHPA
Tissue
- tongue: 48 nTPM
- skeletal muscle: 45 nTPM
- testis: 39 nTPM
- heart muscle: 32 nTPM
- liver: 30 nTPM
- kidney: 29 nTPM
Single-cell type
- late primary spermatocytes: 236 nCPM
- hofbauer cells: 141 nCPM
- early primary spermatocytes: 140 nCPM
- oocytes: 111 nCPM
- extravillous trophoblasts: 94 nCPM
- breast lactating cells: 94 nCPM
Immune cell
- eosinophil: 80 nTPM
- non-classical monocyte: 76 nTPM
- intermediate monocyte: 72 nTPM
- plasmacytoid DC: 63 nTPM
- classical monocyte: 55 nTPM
- myeloid DC: 51 nTPM
Brain region
- white matter: 20 nTPM
- spinal cord: 15 nTPM
- cerebellum: 15 nTPM
- medulla oblongata: 15 nTPM
- pons: 14 nTPM
- choroid plexus: 12 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.07
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.99
- DepMap mean gene effect
- -1.23
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GPN3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GPN3 as an antibody target. Whether an autoantibody or antibody against GPN3 could matter depends on whether native GPN3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GPN3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GPN3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...